Results 161 to 170 of about 2,141 (223)

Interferon-gamma blocking as a promising treatment for severe liver dysfunction in secondary hemophagocytic lymphohistiocytosis after liver transplantation. [PDF]

JPGN Rep
Chen C, Zhou T, Jin J, Luo Y, Shen L, Xia Q, Qian Y.   +6 more
europepmc   +1 more source

Primary Gastrointestinal B-Cell Lymphomas: A Clinicopathological Review. [PDF]

J Hematol
Elsharawi I, Liwski C.
europepmc   +1 more source

Commentary on chapter by Klintmalm: Tacrolimus [PDF]

, 1999
Fung, JJ, Starzl, TE
core  

Incidence, screening, and management of <i>de novo</i> malignancies in liver transplant patients: A review. [PDF]

World J Transplant
Singh A, Singh C, Dhaliwal A, Singh N, Kumar V, Sohal A, Schneider J.   +6 more
europepmc   +1 more source

El eslabón perdido: microquimerismo y supervivencia del injerto [PDF]

, 1999
Demetris, AJ, Murase, N, Rao, AS, Starzl, TE, Thomson, AW, Trucco, M   +5 more
core  

Core features and inherent diversity of post-acute infection syndromes. [PDF]

Front Immunol
Trautmann A.
europepmc   +1 more source

Treatment of post-treatment Lyme disease symptoms-a systematic review. [PDF]

Eur J Neurol
Dersch R, Torbahn G, Rauer S.
europepmc   +1 more source

Cutaneous Epstein-Barr virus-positive polymorphous posttransplantation lymphoproliferative disorder responding to rituximab. [PDF]

JAAD Case Rep
Chen M, Hwang J, Germanas J.
europepmc   +1 more source

Posttransplant Lymphoproliferative Disorder (PTLD): 24 Years of Experience at a Referral Center in São Paulo, Brazil. Can Differences in Prevalence and Subtype of EBV Infection in the Population Influence the Results? A Retrospective Cohort Study. [PDF]

J Transplant
Vargas JC, Helman R, Durão MS, de Arruda EF, Afonso JE, Carraro RM, Curvelo LA, Felga GEG, Matielo CEL, Almeida PH, Pasqualin D, Stanzione R, Perrone C, Perini G, Hamerschlak N.   +14 more
europepmc   +1 more source